Breaking News
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
Biogen has agreed to acquire private biotechnology company RayThera Inc. for up to $1 billion in an upfront payment plus milestone-based contingent payments. The acquisition adds multiple anti-inflammatory assets to Biogen's immunology portfolio, with RayThera's lead candidate expected to enter Phase 1 development in early Q3 2026. The transaction is anticipated to close in Q3 2026.
Latest News
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
Biogen has agreed to acquire private biotechnology company RayThera Inc. for up to $1 billion in an upfront payment plus milestone-based contingent payments. The acquisition adds multiple anti-inflammatory assets to Biogen's immunology portfolio, with RayThera's lead candidate expected to enter Phase 1 development in early Q3 2026. The transaction is anticipated to close in Q3 2026.
POET DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages POET Technologies Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 29 Deadline in Securities Class Action First Filed by the Firm – POET
Rosen Law Firm has filed a securities class action lawsuit against POET Technologies Inc. for allegedly making false and misleading statements regarding its tax status as a potential passive foreign investment company (PFIC), failing to disclose negative tax implications for U.S. stockholders, and an executive's violation of a non-disclosure agreement. Investors with losses exceeding $100,000 are encouraged to join the class action before the June 29, 2026 deadline.
Investar Holding Corporation Declares Quarterly Common and Preferred Stock Cash Dividends
Investar Holding Corporation announced a quarterly cash dividend of $0.12 per share for common stock holders, representing a 9% increase from the prior quarter. The company also declared a $16.25 per share dividend for holders of its 6.5% Series A Non-Cumulative Perpetual Convertible Preferred Stock. This marks the 51st quarterly dividend paid by the company.
Trinity Capital Declares Monthly Cash Distribution of $0.17 per Share for the Third Quarter of 2026
Trinity Capital Inc. (NASDAQ: TRIN) announced a monthly regular dividend of $0.17 per share for July, August, and September 2026. The dividend remains consistent with distributions from the first six months of 2026, and shareholders have received consistent or increased dividends for over six consecutive years. The company aims to distribute 90-100% of its taxable quarterly income to qualify as a regulated investment company.
[Latest] Global Ear Health Market Size/Share Worth USD 16.87 Billion by 2035 at a 5.7% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
The global ear health market is projected to grow from USD 10.12 billion in 2025 to USD 16.87 billion by 2035, at a CAGR of 5.7%. Growth is driven by rising hearing loss rates, aging populations, noise pollution exposure, and technological advancements in hearing aids and diagnostic devices. North America currently dominates the market, while Asia Pacific shows the fastest growth potential.
FS KKR CAPITAL ALERT: Bragar Eagel & Squire, P.C. Reminds FS KKR Capital Corp. Investors They Have Until July 6th to Seek Lead Plaintiff Role With The Firm
A class action lawsuit has been filed against FS KKR Capital Corp. (FSK) in the U.S. District Court for the Eastern District of Pennsylvania. The lawsuit alleges that the company made false and misleading statements regarding its portfolio restructuring efforts, investment valuations, and distribution strategy during the period from May 8, 2024 to February 25, 2026. Investors have until July 6, 2026 to apply to be appointed as lead plaintiff.
ADMA LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. and Encourages Investors to Contact the Firm
A class action lawsuit has been filed against ADMA Biologics for allegedly making false statements about its business operations. The lawsuit claims ADMA engaged in undisclosed related party transactions, used channel stuffing to inflate revenues, and lacked adequate internal controls. Following a short report by Culper Research on March 24, 2026, ADMA's stock fell 16.63%. Investors who purchased ADMA securities between August 9, 2024 and March 25, 2026 can join the lawsuit.
Why Meta Platforms Stock Plummeted by Over 5% on Wednesday
Meta Platforms stock dropped over 5% on Wednesday following reports that Emily Dalton Smith, head of product for Meta's AI For Work initiative, is departing the company. The departure raised investor concerns about Meta's internal AI integration efforts, a critical area for the tech industry. The stock decline was also influenced by broader bearishness in the tech sector.
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Via Transportation, Inc. and Encourages Investors to Contact the Firm
A class action lawsuit has been filed against Via Transportation, Inc. alleging that its September 2025 IPO offering documents were false and misleading. The complaint claims Via omitted material facts about declining growth and inability to expand in Germany. Following a March 2026 research report questioning Via's business model characterization, the stock fell 59.7% from its $46 IPO price to $18.51. Investors have until August 10, 2026 to apply as lead plaintiff.
Apple Will Raise Prices Due To Soaring Memory Costs: CEO Tim Cook Says 'This Is A 100-Year Flood'
Apple CEO Tim Cook announced the company will raise prices across its product lineup due to skyrocketing memory and storage component costs. Cook described the situation as a "100-year flood," citing a dramatic reallocation of DRAM and NAND supply toward AI infrastructure by major tech companies. Memory chip prices have quadrupled as companies like Google, Microsoft, Meta, and Amazon expand AI capex.